Investors

Investors arrow
Print E-mail
Investor Relations

Peregrine Pharmaceuticals, Inc.

Corporate and Media Relations

Investors

14282 Franklin Avenue,
Tustin, CA 92780
Phone: 714-508-6000
Fax: 714-838-5817

Linda Donaldson
14282 Franklin Avenue
Tustin, CA 92780

Tel: 714-508-6067
Fax: 714-838-5817
pr@peregrineinc.com

GendeLLindheim BioCom Partners, LLC
Barbara Lindheim
48 Wall Street, Suite 1100
New York, NY 10005 

Tel: 212-918-4949
Tel: 800-987-8256


Featured Events  
Jan 13, 2010 at 2:00 PM PT
3rd Annual OneMedPlace Finance Forum
Dec 10, 2009 at 11:30 AM ET
Second Quarter Fiscal Year 2010 Financial Results Conference Call


Recent Press Releases  
Feb 2, 2010
Peregrine Pharmaceuticals to Present at the 12th Annual BIO CEO and Investor Conference
Jan 11, 2010
Peregrine Pharmaceuticals Appoints Dr. Marvin R. Garovoy as Head of Clinical Science

View all releases »

Upcoming Events  
Feb 9, 2010 at 3:30 PM ET
12th Annual BIO CEO and Investor Conference

View all events & presentations »

Stock Information  
NASDAQ:PPHM
$3.13   + 0.08
Feb 8, 2010
3:59 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Shareholder Tools  
 
 
© 2003/2010 Peregrine Pharmaceuticals Inc., All Rights Reserved   Disclaimer | Safe Harbor